Lessons Learned from the MAUDE Database on Transvaginal Synthetic Mesh and Sling Reports

Annie Abraham, Kristina Tzartzeva, Alana Christie, Philippe Zimmern

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Introduction We investigated the volume and sources of MDRs (medical device reports) on transvaginal mesh and sling complications in the FDA (Food and Drug Administration) MAUDE (Manufacturer and User Facility Device Experience) database. Methods We extracted and analyzed reports on transvaginal mesh and sling complications submitted to the MAUDE database from 2008 to 2014. We also examined reports for major mesh and sling brands as well as reporter occupation. Results The number of reports on transvaginal mesh and sling implants increased slowly from 2008 to 2011, ending with 1,687 reports in 2011. In 2012 the volume increased nearly sevenfold, yielding 11,710 reports. The year 2013 witnessed an even greater surge, with a total of 43,680 complication reports. This trend quickly subsided in 2014 as the number of reports decreased to 5,467. Meanwhile, the number of attorney submitted reports greatly increased by a factor of 18.6 in 2012 and then by a smaller increment in 2013. Physician submitted reports increased threefold in 2012 and then by a factor of 5.6 in 2013. Unfortunately more than half of the 2013 reports list an unknown occupation for the reporter. Conclusions The marked growth of transvaginal mesh and sling reports in the MAUDE database, as well as attorney submitted reports, correlated with the timing of the 2011 FDA issued notification warning the public about the risk of complications associated with transvaginal mesh placement. Despite some shortcomings, the MAUDE database offers an appropriate tool to measure overall trends of device complications and serves as a vehicle for the FDA to alert the public regarding potential dangers.

Original languageEnglish (US)
Pages (from-to)111-117
Number of pages7
JournalUrology Practice
Volume4
Issue number2
DOIs
StatePublished - Mar 1 2017

Fingerprint

Databases
Equipment and Supplies
United States Food and Drug Administration
Lawyers
Occupations
Physicians
Growth

Keywords

  • pelvic organ prolapse
  • postoperative complications
  • suburethral slings
  • surgical mesh
  • urinary incontinence

ASJC Scopus subject areas

  • Urology

Cite this

Lessons Learned from the MAUDE Database on Transvaginal Synthetic Mesh and Sling Reports. / Abraham, Annie; Tzartzeva, Kristina; Christie, Alana; Zimmern, Philippe.

In: Urology Practice, Vol. 4, No. 2, 01.03.2017, p. 111-117.

Research output: Contribution to journalArticle

Abraham, Annie ; Tzartzeva, Kristina ; Christie, Alana ; Zimmern, Philippe. / Lessons Learned from the MAUDE Database on Transvaginal Synthetic Mesh and Sling Reports. In: Urology Practice. 2017 ; Vol. 4, No. 2. pp. 111-117.
@article{75b498d9d9f7482da5c7d6d309e3f993,
title = "Lessons Learned from the MAUDE Database on Transvaginal Synthetic Mesh and Sling Reports",
abstract = "Introduction We investigated the volume and sources of MDRs (medical device reports) on transvaginal mesh and sling complications in the FDA (Food and Drug Administration) MAUDE (Manufacturer and User Facility Device Experience) database. Methods We extracted and analyzed reports on transvaginal mesh and sling complications submitted to the MAUDE database from 2008 to 2014. We also examined reports for major mesh and sling brands as well as reporter occupation. Results The number of reports on transvaginal mesh and sling implants increased slowly from 2008 to 2011, ending with 1,687 reports in 2011. In 2012 the volume increased nearly sevenfold, yielding 11,710 reports. The year 2013 witnessed an even greater surge, with a total of 43,680 complication reports. This trend quickly subsided in 2014 as the number of reports decreased to 5,467. Meanwhile, the number of attorney submitted reports greatly increased by a factor of 18.6 in 2012 and then by a smaller increment in 2013. Physician submitted reports increased threefold in 2012 and then by a factor of 5.6 in 2013. Unfortunately more than half of the 2013 reports list an unknown occupation for the reporter. Conclusions The marked growth of transvaginal mesh and sling reports in the MAUDE database, as well as attorney submitted reports, correlated with the timing of the 2011 FDA issued notification warning the public about the risk of complications associated with transvaginal mesh placement. Despite some shortcomings, the MAUDE database offers an appropriate tool to measure overall trends of device complications and serves as a vehicle for the FDA to alert the public regarding potential dangers.",
keywords = "pelvic organ prolapse, postoperative complications, suburethral slings, surgical mesh, urinary incontinence",
author = "Annie Abraham and Kristina Tzartzeva and Alana Christie and Philippe Zimmern",
year = "2017",
month = "3",
day = "1",
doi = "10.1016/j.urpr.2016.03.020",
language = "English (US)",
volume = "4",
pages = "111--117",
journal = "Urology Practice",
issn = "2352-0779",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Lessons Learned from the MAUDE Database on Transvaginal Synthetic Mesh and Sling Reports

AU - Abraham, Annie

AU - Tzartzeva, Kristina

AU - Christie, Alana

AU - Zimmern, Philippe

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Introduction We investigated the volume and sources of MDRs (medical device reports) on transvaginal mesh and sling complications in the FDA (Food and Drug Administration) MAUDE (Manufacturer and User Facility Device Experience) database. Methods We extracted and analyzed reports on transvaginal mesh and sling complications submitted to the MAUDE database from 2008 to 2014. We also examined reports for major mesh and sling brands as well as reporter occupation. Results The number of reports on transvaginal mesh and sling implants increased slowly from 2008 to 2011, ending with 1,687 reports in 2011. In 2012 the volume increased nearly sevenfold, yielding 11,710 reports. The year 2013 witnessed an even greater surge, with a total of 43,680 complication reports. This trend quickly subsided in 2014 as the number of reports decreased to 5,467. Meanwhile, the number of attorney submitted reports greatly increased by a factor of 18.6 in 2012 and then by a smaller increment in 2013. Physician submitted reports increased threefold in 2012 and then by a factor of 5.6 in 2013. Unfortunately more than half of the 2013 reports list an unknown occupation for the reporter. Conclusions The marked growth of transvaginal mesh and sling reports in the MAUDE database, as well as attorney submitted reports, correlated with the timing of the 2011 FDA issued notification warning the public about the risk of complications associated with transvaginal mesh placement. Despite some shortcomings, the MAUDE database offers an appropriate tool to measure overall trends of device complications and serves as a vehicle for the FDA to alert the public regarding potential dangers.

AB - Introduction We investigated the volume and sources of MDRs (medical device reports) on transvaginal mesh and sling complications in the FDA (Food and Drug Administration) MAUDE (Manufacturer and User Facility Device Experience) database. Methods We extracted and analyzed reports on transvaginal mesh and sling complications submitted to the MAUDE database from 2008 to 2014. We also examined reports for major mesh and sling brands as well as reporter occupation. Results The number of reports on transvaginal mesh and sling implants increased slowly from 2008 to 2011, ending with 1,687 reports in 2011. In 2012 the volume increased nearly sevenfold, yielding 11,710 reports. The year 2013 witnessed an even greater surge, with a total of 43,680 complication reports. This trend quickly subsided in 2014 as the number of reports decreased to 5,467. Meanwhile, the number of attorney submitted reports greatly increased by a factor of 18.6 in 2012 and then by a smaller increment in 2013. Physician submitted reports increased threefold in 2012 and then by a factor of 5.6 in 2013. Unfortunately more than half of the 2013 reports list an unknown occupation for the reporter. Conclusions The marked growth of transvaginal mesh and sling reports in the MAUDE database, as well as attorney submitted reports, correlated with the timing of the 2011 FDA issued notification warning the public about the risk of complications associated with transvaginal mesh placement. Despite some shortcomings, the MAUDE database offers an appropriate tool to measure overall trends of device complications and serves as a vehicle for the FDA to alert the public regarding potential dangers.

KW - pelvic organ prolapse

KW - postoperative complications

KW - suburethral slings

KW - surgical mesh

KW - urinary incontinence

UR - http://www.scopus.com/inward/record.url?scp=85011422868&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011422868&partnerID=8YFLogxK

U2 - 10.1016/j.urpr.2016.03.020

DO - 10.1016/j.urpr.2016.03.020

M3 - Article

AN - SCOPUS:85011422868

VL - 4

SP - 111

EP - 117

JO - Urology Practice

JF - Urology Practice

SN - 2352-0779

IS - 2

ER -